TERN - Terns Pharmaceuticals GAAP EPS of -$0.26 beats by $0.03 August, 05 2025 05:27 PM Terns Pharmaceuticals Inc. 2025-08-05 17:27:39 ET More on Terns Pharmaceuticals Terns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology Catalysts Seeking Alpha’s Quant Rating on Terns Pharmaceuticals Historical earnings data for Terns Pharmaceuticals Financial information for Terns Pharmaceuticals For further details see: Terns Pharmaceuticals GAAP EPS of -$0.26 beats by $0.03